Der weltweite Markt für extrakorporale Membranoxygenierung wurde im Jahr 2021 auf 546,73 Millionen US-Dollar geschätzt und wird bis 2028 voraussichtlich 677,64 Millionen US-Dollar erreichen. Der Markt wird zwischen 2022 und 2028 voraussichtlich um 3,1 % CAGR wachsen.
Extrakorporale Membranoxygenierung (extrakorporale Membranoxygenierung) ist eine Behandlung zur Blutzirkulation durch eine künstliche Lunge. Das System hilft, einen Herz-Lungen-Bypass-Weg außerhalb des Körpers bereitzustellen. Damit werden auch Patienten unterstützt, die eine Lungentransplantation benötigen. Dem Markt für extrakorporale Membranoxygenierung wird Wachstum zugeschrieben die zunehmende Prävalenz von Herz-Kreislauf-Erkrankungen und Atemversagen und die zunehmende Einführung der extrakorporalen Membranoxygenierung bei Lungentransplantationsverfahren. Komplikationen im Zusammenhang mit der extrakorporalen Membranoxygenierung behindern jedoch das Wachstum des Marktes.
Strategische Einblicke
Lukrative Regionen im Markt für extrakorporale Membranoxygenierung
Market Insights
Zunehmende Akzeptanz der extrakorporalen Membranoxygenierung bei Lungentransplantationsverfahren treibt das Marktwachstum der extrakorporalen Membranoxygenierung voran
Lungentransplantation ist eine lebensrettende Behandlungsoption für Patienten mit Lungenerkrankungen im Endstadium, wie z wie COPD, Idiopathische Lungenfibrose (IPF ) und Mukoviszidose, um die Lebensqualität zu verbessern. Die extrakorporale Membranoxygenierung ist ein vielseitiges Werkzeug, das in allen Phasen der Lungentransplantation, wie präoperativen, intraoperativen und postoperativen Phasen, eingesetzt wird. Es fungiert als Brücke für Patienten, die sich einer Lungentransplantation unterziehen. Daher nimmt die Einführung der extrakorporalen Membranoxygenierung während der Lungentransplantation schnell zu, um Patienten mit lebensbedrohlichen Lungenerkrankungen zu behandeln. Laut dem Scientific Registry of Transplant Recipients (SRTR) werden jedes Jahr weltweit etwa 4.600 Lungentransplantationen durchgeführt, davon 55 % in Nordamerika. Laut derselben Quelle wurden ~2.759 Patienten einer Lungentransplantation unterzogen, und ~3.243 Patienten wurden in den USA auf die Warteliste für Lungentransplantationen gesetzt. Die primäre Transplantatdysfunktion (PID) ist die häufigste Todesursache nach einer Lungentransplantation. Daher wird die extrakorporale Membranoxygenierung vorletztes Mal bei der Behandlung der PID nach einer Lungentransplantation eingesetzt. Laut National Library Medicine (NLM) beträgt die Gesamtinzidenz der PID im Jahr 2022 30 %, wobei die Risikofaktoren präoperative Spenderlungenischämie, Organerwerb, Konservierungstechniken sowie intraoperative Organimplantation und Reperfusion umfassen. Daher wächst die Nachfrage nach Geräten zur extrakorporalen Membranoxygenierung zur Behandlung von PID-Patienten.
Modalitätsbasierte Einblicke
Der globale Markt für extrakorporale Membranoxygenierung ist, basierend auf der Modalität, in venoarterielle extrakorporale Membranoxygenierung, venovenöse extrakorporale Membranoxygenierung und arteriovenöse extrakorporale Membranoxygenierung unterteilt. Das Segment der venoarteriellen extrakorporalen Membranoxygenierung hielt im Jahr 2021 den größten Marktanteil. Darüber hinaus wird erwartet, dass dasselbe Segment im Prognosezeitraum die höchste CAGR von 3,8 % auf dem Markt verzeichnen wird. Die venoarterielle (VA) extrakorporale Membranoxygenierung unterstützt Herz und Lunge des Patienten, indem das Blut durch den Kreislauf gepresst wird, ohne dass es durch das Herz des Patienten gelangt. Diese Art der extrakorporalen Membranoxygenierung entnimmt Blut aus einer großen Vene und führt es zurück in eine große Arterie, sodass sauerstoffreiches Blut durch den Körper zirkulieren kann, selbst wenn das Herz zu schwach zum Pumpen ist. Die veno-arterielle extrakorporale Membranoxygenierung (VA-extrakorporale Membranoxygenierung) hat in den letzten zehn Jahren eine breite Anwendung gefunden. Es ist eine wirksame und wertvolle therapeutische Option bei refraktärem kardiogenem Schock verschiedener Ätiologien. Es zeigte vielversprechende Ergebnisse in der speziellen Situation des Herzstillstands im Krankenhaus, und Überlebensraten mit guten neurologischen Ergebnissen werden zwischen 20 % und 40 % gemeldet.
Markt für extrakorporale Membranoxygenierung nach Modalität 2021 und 2028< /h3>
Altersgruppenbasierte Einblicke
Basierend auf der Altersgruppe ist der weltweite Markt für extrakorporale Membranoxygenierung in Erwachsene, Kinder und Neugeborene unterteilt. Das Segment für Erwachsene hielt 2021 den größten Marktanteil und wird voraussichtlich im Zeitraum 2022-2028 eine CAGR von 3,7 % verzeichnen. Die extrakorporale Membranoxygenierung hilft erwachsenen Patienten, die an Herz- oder Atemstillstand leiden. Darüber hinaus haben die jüngsten technologischen Fortschritte bei extrakorporalen Membranoxygenierungskreisläufen zu einer Verringerung der Rate technischer Probleme und Komplikationen geführt.
Extrakorporale Membranoxygenierung Marktsegmentierung
Der Markt für extrakorporale Membranoxygenierung ist nach Modalität, Anwendung, Altersgruppe und Geographie segmentiert. Basierend auf der Modalität ist der Markt in venoarterielle extrakorporale Membranoxygenierung, venovenöse extrakorporale Membranoxygenierung unterteilt , arteriovenöse extrakorporale Membranoxygenierung. Je nach Anwendung wird der Markt für extrakorporale Membranoxygenierung in Atemwege und Kardiologie unterteilt. In Bezug auf den Endverbraucher ist der Markt für die extrakorporale Membranoxygenierung in Erwachsene, Kinder und Neugeborene unterteilt. Geografisch ist der Markt für extrakorporale Membranoxygenierung in Nordamerika (USA, Kanada und Mexiko), Europa (Großbritannien, Deutschland, Frankreich, Italien, Spanien und das übrige Europa), den asiatisch-pazifischen Raum (China, Japan, Indien, Australien, Südkorea und der Rest des asiatisch-pazifischen Raums), Naher Osten & Afrika (VAE, Saudi-Arabien, Afrika und der Rest des Nahen Ostens und Afrikas) sowie Süd- und Mittelamerika (Brasilien, Argentinien und der Rest von Süd- und Mittelamerika).
Produkteinführungen und -zulassungen sind häufig angewandte Strategien von Unternehmen, um ihre globale Präsenz und ihr Produktportfolio zu erweitern und den Marktanteil der extrakorporalen Membranoxygenierung zu dominieren. Darüber hinaus setzen die Marktteilnehmer auf die Partnerschaftsstrategie, um ihren Kundenkreis zu vergrößern, was es ihnen wiederum ermöglicht, ihren Markennamen weltweit aufrechtzuerhalten. Aufgrund der Entwicklung neuer innovativer Produkte durch Marktakteure wird erwartet, dass der Markt in den kommenden Jahren florieren wird.
Firmenprofile
- Terumo Group
- Medtronic Plc
- MicroPort Scientific Corporation
- LivaNova Plc
- Nipro Medical Corporation
- Eurosets SRL
- Getinge AB
- Braile Biomedica
- Fresenius Medical Care AG & Co KGaA
- ABIOMED Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global extracorporeal membrane oxygenation market based on modality is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. In 2021, the venoarterial extracorporeal membrane oxygenation segment accounted for the highest share, moreover the same segment is expected to grow faster at a CAGR of 3.8% in the forecast period.
The extracorporeal membrane oxygenation market majorly consists of the players such as Terumo Group, Medtronic Plc. MicroPort Scientific Corporation, LivaNova Plc, Nipro Medical Corporation, Eurosets S.R.L., Getinge AB, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, and ABIOMED Inc.
The complications associated with extracorporeal membrane oxygenation is expected to restrict the market growth during the forecast period
Factors such as the rising prevalence of cardiovascular diseases and respiratory failures and further growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures.
Extracorporeal membrane oxygenation (ECMO) is a treatment used for the circulation of blood through an artificial lung back into the bloodstream. The system enables to provide heart-lung bypass route outside the body. This also provides support to patients who need a lung transplant. The main purpose of extracorporeal membrane oxygenation is to provide oxygen to the body to heal or rest.
The global extracorporeal membrane oxygenation market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 3.9% during the forecast period.
The List of Companies - Extracorporeal Membrane Oxygenation Market
- Terumo Group
- Medtronic Plc
- MicroPort Scientific Corporation
- LivaNova Plc
- Nipro Medical Corporation
- Eurosets S.R.L.
- Getinge AB
- Braile Biomedica
- Fresenius Medical Care AG & Co KGaA
- ABIOMED Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Nov 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Nov 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Nov 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)